Zantac Cancer Concerns Cause FDA To Request Withdrawing Products From Market
On April 1, 2020 the United States Food and Drug Association (“FDA”) announced that it was requesting drug manufacturers withdraw all prescription and over-the-counter (“OTC”) drugs containing ranitidine from the market immediately. This is the latest step in the FDA’s ongoing investigation into the cancer risks of ranitidine products such as the popular brand name […]
Zantac Cancer Concerns Cause FDA To Request Withdrawing Products From Market Read More »